Ziauddin University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Karachi Pakistan (1995)

Organization Overview

First Clinical Trial
2010
NCT01150162
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

DR ZIAUDDIN HOSPITAL, CLIFTON CAMPUS | Dr. Ziauddin University Hospital | Ziauddin | Ziauddin Hospital | Ziauddin University | ZIAUDDIN UNIVERSITY HOSPITAL | Ziauddin University hospital Karachi | Ziauddin University Hospital Karachi | Ziauddin University Karachi, Sindh, Pakistan | ziauddin university north campus | Ziauddin University, shahrae ghalib, Clifton, Karachi. Pakistan.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 1)

Disease (Phase 2)

Fever (Phase 4)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis, Chronic (Phase 2)

Hepatitis D (Phase 2)

Hepatitis D, Chronic (Phase 2)

Neuralgia (Phase 4)

Pain, Postoperative (Phase 4)

Periodontitis (Phase 1)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Stomach Ulcer (Phase 3)

Typhoid Fever (Phase 4)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 32